Novartis digital initiatives to create awareness of heart failure can positively impact patient's lives in India


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Novartis Building
Novartis has taken a lead in actively promoting heart failure awareness across India through unbranded digital initiatives that can successfully deliver message to a large population at risk.

According to GlobalData’s Pharma Intelligence Center, the diagnosed prevalence of congestive heart failure in India is currently around 9.61 million with an annual growth of 4%.

Venkat Kartheek Vale, Pharma Analyst at GlobalData, comments: “The growing incidence of cardiovascular risk due to an aging population and an increasingly unhealthy lifestyle as well as the lack of awareness of the symptomatic difference between heart failure and heart attack are the leading causes of heart failure in India. Novartis has rightly targeted this underserved community through its digital campaigns by increasing education about clear symptoms of heart failure with an aim to spread awareness and recommend the appropriate treatment.”

Novartis’ leading drug for heart failure, Entresto (Vymada in India), is undergoing label expansion studies in chronic heart failure with preserved ejection fraction (HFpEF), post-acute myocardial infarction, and pediatric heart failure in many countries including India. Novartis plans to submit the supplemental NDA for Entresto for treating HFpEF in the US during H1 2020 with approval expected in H2 2020

Vale concludes: “Novartis’ digital campaigns will help expanding the patient base who require treatment support and this will indirectly help increase the sales of Vymada in India. In addition, with new approvals expected in other cardiovascular (CV) indications, Novartis can utilize its existing digital assets to create awareness of the new diseases thereby positioning itself strongly in the CV space and impact treatment trends in India.”

Tags : #Novartis #HeartFailure #Awareness #India

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026